In the five major technical routes of the new crown vaccine, mRNA vaccine belongs to the latest generation of technology, the protection rate of the two mRNA vaccines in foreign countries is about 95%, and the domestic mRNA vaccine is said to be effective as a foreign product, but the domestic progress is slightly slower than that of foreign countries, and the latest research is used as a reinforcing needle.
According to reports, according to the information of the government service platform of the Ministry of Science and Technology, the "Phase IIIb clinical trial evaluating the enhancement of the immunogenicity and safety of the novel coronavirus mRNA vaccine in people aged 18 to 59 and 60 years old who have been vaccinated with the new coronavirus inactivated vaccine" was approved.
The applicant is the Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, and the approval time is November 2021. At present, the domestic mRNA vaccine manufacturers mainly involve Aibo Biology, Watson Biology, Si Microorganism, etc., affected by this, Watson Biology straight up, the maximum increase of more than 19%, the close fell back to 13% of the increase.
For the impact of this matter, Watson Bio replied to the media that the matter belongs to the public information of the Ministry of Science and Technology, and the announcement of the Ministry of Science and Technology shall prevail.
- THE END -
Please indicate the source of reprint: fast technology
![Explosive melon, the richest man quietly built a warehouse Watson creature, pay close attention to the melon of the possible more preemptive Watson creatures a brain hole[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)